| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.004 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.084 | 0.006 |